Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
Revenue Contraction
Trending lower, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$53.40M
↑ 36% above average
Average (9y)
$39.14M
Historical baseline
Range
High:$65.49M
Low:$4.36M
CAGR
+32.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $53.40M | -18.5% |
| 2023 | $65.49M | +37.5% |
| 2022 | $47.64M | +24.2% |
| 2021 | $38.35M | -39.0% |
| 2020 | $62.90M | +15.0% |
| 2019 | $54.69M | +59.7% |
| 2018 | $34.24M | +62.4% |
| 2017 | $21.08M | +129.1% |
| 2016 | $9.20M | +110.8% |
| 2015 | $4.36M | - |